The neoplastic potential of germ cells changes as they progress through normal development. This is reflected in correlations between the stage of origin, defined by genetic markers, and the morphology and natural history of resultant tumors. The determinants of this effect are unknown, and this tidy proposes to evaluate several possibilities in a collection of human germ cell tumors of defined origin. One is that cellular oncogenies, c-oncs, which are regulated in normal germ cells, are aberrantly expressed and/or mutated in the tumors. Gross cytogenetic anomalies will also be evaluated, as some abnormalities appear consistently in specific tumor types. Coincident with these human studies, parthenogenetic mouse ova will be used as a model system to directly study gene expression from the time of neoplastic transformation through proliferation into a teratoma. Using probes for genes regulated during normal gametogenesis and embryogenesis, including c-oncs, parthenogenetic embryo expression will be contrasted with normal embryos and mature teratomas from the same lineage. A particular effort will be made to determine if the patterns of c-onc expression present in the stem cell at the time of neoplastic transformation are altered during clonal proliferation of tumor cells.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29CA049859-04
Application #
3459456
Study Section
Pathology B Study Section (PTHB)
Project Start
1989-04-01
Project End
1994-03-31
Budget Start
1992-04-01
Budget End
1993-03-31
Support Year
4
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Sinnock, K L; Perez-Atayde, A R; Boynton, K A et al. (1996) Clonal analysis of sacrococcygeal ""teratomas"". Pediatr Pathol Lab Med 16:865-75
Mutter, G L; Chaponot, M L; Fletcher, J A (1995) A polymerase chain reaction assay for non-random X chromosome inactivation identifies monoclonal endometrial cancers and precancers. Am J Pathol 146:501-8
Borriello, F; Weinberg, D S; Mutter, G L (1994) Evaluation of gene deletions by quantitative polymerase chain reaction. Experience with the alpha-thalassemia model. Diagn Mol Pathol 3:246-54
Roberts, D J; Mutter, G L (1994) Advances in the molecular biology of gestational trophoblastic disease. J Reprod Med 39:201-8
Mutter, G L; Pomponio, R J; Berkowitz, R S et al. (1993) Sex chromosome composition of complete hydatidiform moles: relationship to metastasis. Am J Obstet Gynecol 168:1547-51
Lobel, S M; Pomponio, R J; Mutter, G L (1993) The sex ratio of normal and manipulated human sperm quantitated by the polymerase chain reaction. Fertil Steril 59:387-92
Mutter, G L; Pomponio, R J (1991) Molecular diagnosis of sex chromosome aneuploidy using quantitative PCR. Nucleic Acids Res 19:4203-7
Robertson, N G; Pomponio, R J; Mutter, G L et al. (1991) Testis-specific expression of the human MYCL2 gene. Nucleic Acids Res 19:3129-37